SE453636B - 1,2,3,4-tetrahydro-1,1,4,4-tetrametyl-6-(alfa-metylstyryl)naftalen till anvendning som farmaceutisk substans for minskning av talgsekretionen - Google Patents

1,2,3,4-tetrahydro-1,1,4,4-tetrametyl-6-(alfa-metylstyryl)naftalen till anvendning som farmaceutisk substans for minskning av talgsekretionen

Info

Publication number
SE453636B
SE453636B SE8303732A SE8303732A SE453636B SE 453636 B SE453636 B SE 453636B SE 8303732 A SE8303732 A SE 8303732A SE 8303732 A SE8303732 A SE 8303732A SE 453636 B SE453636 B SE 453636B
Authority
SE
Sweden
Prior art keywords
compound
tetrahydro
tetramethyl
formula
methylstyryl
Prior art date
Application number
SE8303732A
Other languages
English (en)
Swedish (sv)
Other versions
SE8303732L (sv
SE8303732D0 (sv
Inventor
A Boris
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE8303732D0 publication Critical patent/SE8303732D0/xx
Publication of SE8303732L publication Critical patent/SE8303732L/xx
Publication of SE453636B publication Critical patent/SE453636B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/47—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with a bicyclo ring system containing ten carbon atoms
    • C07C13/48—Completely or partially hydrogenated naphthalenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Dental Preparations (AREA)
SE8303732A 1982-07-02 1983-06-30 1,2,3,4-tetrahydro-1,1,4,4-tetrametyl-6-(alfa-metylstyryl)naftalen till anvendning som farmaceutisk substans for minskning av talgsekretionen SE453636B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US39475482A 1982-07-02 1982-07-02

Publications (3)

Publication Number Publication Date
SE8303732D0 SE8303732D0 (sv) 1983-06-30
SE8303732L SE8303732L (sv) 1984-01-03
SE453636B true SE453636B (sv) 1988-02-22

Family

ID=23560291

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8303732A SE453636B (sv) 1982-07-02 1983-06-30 1,2,3,4-tetrahydro-1,1,4,4-tetrametyl-6-(alfa-metylstyryl)naftalen till anvendning som farmaceutisk substans for minskning av talgsekretionen

Country Status (30)

Country Link
US (1) US4588750A (es)
JP (1) JPS5921630A (es)
KR (1) KR840005341A (es)
AR (1) AR230180A1 (es)
AU (1) AU565242B2 (es)
BE (1) BE897195A (es)
BR (1) BR8303529A (es)
CA (1) CA1221032A (es)
CH (1) CH654287A5 (es)
DE (1) DE3323585A1 (es)
DK (1) DK291583A (es)
DO (1) DOP1983004277A (es)
ES (1) ES8700049A1 (es)
FI (1) FI832432L (es)
FR (1) FR2529458B1 (es)
GB (1) GB2123692B (es)
GR (1) GR79328B (es)
IE (1) IE55206B1 (es)
IL (1) IL69118A (es)
IT (1) IT1169742B (es)
LU (1) LU84892A1 (es)
MC (1) MC1525A1 (es)
NL (1) NL8302346A (es)
NO (1) NO832417L (es)
NZ (1) NZ204767A (es)
PH (1) PH19249A (es)
PT (1) PT76974B (es)
SE (1) SE453636B (es)
ZA (1) ZA834804B (es)
ZW (1) ZW15183A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5110801A (en) * 1984-08-13 1992-05-05 Leveen Harry H Treatment of acne
CA1268125A (en) * 1985-06-28 1990-04-24 F. Hoffmann-La Roche Ag Use of a retinoid
CA1268124A (en) * 1985-06-28 1990-04-24 Werner Bollag Use of a retinoid
ZW7487A1 (en) * 1986-05-23 1987-12-16 Hoffmann La Roche Tetrahydronaphthaline and indane derivatives
US5030765A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
US5030764A (en) * 1986-05-23 1991-07-09 Hoffmann-La Roche Inc. Novel tetrahydronaphthalene and indane derivatives
AT388728B (de) * 1987-03-17 1989-08-25 Hoffmann La Roche Neue tetrahydronaphthalin- und indanderivate
DE3903991A1 (de) * 1989-02-10 1990-08-30 Basf Ag Phenylhydrazone des (beta)-jonons, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
DE3903988A1 (de) * 1989-02-10 1990-08-30 Basf Ag Oxidierte diphenylheteroalkane, ihre herstellung und verwendung
DE3903990A1 (de) * 1989-02-10 1990-08-30 Basf Ag Phenylhydrazone, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
DE3903989A1 (de) * 1989-02-10 1990-09-20 Basf Ag Diphenylheteroalkylderivate, ihre herstellung und daraus hergestellte arzneimittel und kosmetika
GB9315156D0 (en) * 1993-07-22 1993-09-08 Ici Plc Coating compositions
DE10016625A1 (de) 2000-04-04 2001-10-11 Basell Polyolefine Gmbh Gasphasenpolymerisationsverfahren mit Direktkühlsystem
CN1668191A (zh) * 2002-05-20 2005-09-14 威廉·O·克林 皮肤清洁剂组合物和使用方法
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
US20050180940A1 (en) * 2004-02-17 2005-08-18 Puma Jeffrey P. Protect against hair loss

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060228A1 (de) * 1970-12-08 1972-06-15 Hoechst Ag Monostyryl-naphthalin-Derivate,Verfahren zu deren Herstellung und ihre Verwendung als optische Aufhellungsmittel
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
DK159967C (da) * 1977-12-22 1991-06-03 Hoffmann La Roche Analogifremgangsmaade til fremstilling af terapeutisk aktive stilbenderivater

Also Published As

Publication number Publication date
GB2123692A (en) 1984-02-08
AU565242B2 (en) 1987-09-10
JPS5921630A (ja) 1984-02-03
ZA834804B (en) 1984-03-28
DK291583D0 (da) 1983-06-23
ES523760A0 (es) 1986-10-16
US4588750A (en) 1986-05-13
FR2529458B1 (fr) 1986-10-24
ZW15183A1 (en) 1985-01-23
DK291583A (da) 1984-01-03
GB8317991D0 (en) 1983-08-03
PT76974B (en) 1986-06-26
BR8303529A (pt) 1984-02-07
KR840005341A (ko) 1984-11-12
NO832417L (no) 1984-01-03
PT76974A (en) 1983-08-01
IT1169742B (it) 1987-06-03
NZ204767A (en) 1986-06-11
SE8303732L (sv) 1984-01-03
NL8302346A (nl) 1984-02-01
GB2123692B (en) 1986-07-09
IL69118A (en) 1986-07-31
FR2529458A1 (fr) 1984-01-06
LU84892A1 (fr) 1985-03-29
SE8303732D0 (sv) 1983-06-30
CH654287A5 (de) 1986-02-14
MC1525A1 (fr) 1984-04-13
ES8700049A1 (es) 1986-10-16
IT8321896A0 (it) 1983-07-01
IE55206B1 (en) 1990-07-04
CA1221032A (en) 1987-04-28
IL69118A0 (en) 1983-10-31
PH19249A (en) 1986-02-14
FI832432L (fi) 1984-01-03
AU1646583A (en) 1984-01-05
GR79328B (es) 1984-10-22
FI832432A0 (fi) 1983-07-01
IE831548L (en) 1984-01-02
BE897195A (fr) 1984-01-02
DE3323585A1 (de) 1984-01-05
AR230180A1 (es) 1984-03-01
DOP1983004277A (es) 1990-03-20

Similar Documents

Publication Publication Date Title
SE453636B (sv) 1,2,3,4-tetrahydro-1,1,4,4-tetrametyl-6-(alfa-metylstyryl)naftalen till anvendning som farmaceutisk substans for minskning av talgsekretionen
ES2214729T3 (es) Acido 9-cis-retinoico para enfermedades inmunes inducidas por celulas.
KR101365801B1 (ko) 피부 염증 치료를 위한 ｐｕｆａ의 용도
EP0552624B1 (en) Use of 9-cis retinoic acid, salts and esters thereof for the treatment of epithelial tumors
US4201788A (en) Process for alleviating proliferative skin diseases
DE68912459T2 (de) Verwendung von Thromboxan-A2-Rezeptorantagonisten zur Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Hautkrankheiten.
JPH10500700A (ja) メトロニダゾールもしくはメトロニダゾールとクリンダマイシンとの相乗混合物を主成分とする薬剤
US4207315A (en) Process for treating proliferative skin diseases using certain diamino compounds
KR900017590A (ko) 좌창(Acne)치료방법 및 그 약제 조성물
AU2008203101A1 (en) Topical compositions comprising telmesteine for treating dermatological disorders
EP1771166A2 (en) Rxr antagonists in the treatment of inflammatory diseases
JPWO2017111069A1 (ja) 止痒剤
US4007268A (en) Process for alleviating proliferative skin diseases
US3966967A (en) Compositions and methods of treating psoriasis with vinyligs of desmethyl retinoic acid
DE69634494T2 (de) Verwendung von Vitamin-D-Derivaten zur Herstellung eines Medikaments zur Behandlung von malignen Tumormetastasen
PT1515710E (pt) Método de tratamento de rosácea por aplicação tópica de um derivado de ciclo-hexano
EP0606614B1 (en) Nonatetraenoic acid derivative
NL8101987A (nl) De verbinding 4-amino-1-beta-d-ribofuranosyl-1h-imidazo/4.5-c/-pyridine of een farmaceutisch aanvaardbaar zuuradditiezout daarvan; farmaceutisch preparaat.
US8541469B2 (en) Treatment of cell-mediated immune diseases
EP0207421B1 (de) Verwendung eines Retinoids zur Herstellung eines antikeratinisierenden Arzneimittels
DE3800101A1 (de) Verwendung einer wirkstoffkombination zur behandlung rheumatischer erkrankungen
PL184625B1 (pl) Nowe pochodne kwasu nonatetraenowego i zawierające je kompozycje farmaceutyczne
WO2003075913A1 (en) Topical compostions comprising furfuryl derivatives and their use for the treatment of dermatologic disorders

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8303732-5

Effective date: 19940210

Format of ref document f/p: F